Xenetic Biosciences, Inc.

DB:3XB0 Stok Raporu

Piyasa değeri: €5.0m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Xenetic Biosciences Yönetim

Yönetim kriter kontrolleri 3/4

We currently do not have sufficient information about the CEO.

Anahtar bilgiler

Jeff Eisenberg

İcra Kurulu Başkanı

US$632.8k

Toplam tazminat

CEO maaş yüzdesi63.9%
CEO görev süresi5.8yrs
CEO sahipliğin/a
Yönetim ortalama görev süresi6.3yrs
Yönetim Kurulu ortalama görev süresi4.4yrs

Son yönetim güncellemeleri

Recent updates

CEO Tazminat Analizi

Jeff Eisenberg'un ücretlendirmesi Xenetic Biosciences'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Mar 31 2023n/an/a

-US$6m

Dec 31 2022US$633kUS$404k

-US$7m

Sep 30 2022n/an/a

-US$7m

Jun 30 2022n/an/a

-US$7m

Mar 31 2022n/an/a

-US$6m

Dec 31 2021US$750kUS$368k

-US$6m

Sep 30 2021n/an/a

-US$5m

Jun 30 2021n/an/a

-US$11m

Mar 31 2021n/an/a

-US$11m

Dec 31 2020US$446kUS$350k

-US$11m

Sep 30 2020n/an/a

-US$11m

Jun 30 2020n/an/a

-US$14m

Mar 31 2020n/an/a

-US$14m

Dec 31 2019US$603kUS$300k

-US$18m

Sep 30 2019n/an/a

-US$19m

Jun 30 2019n/an/a

-US$10m

Mar 31 2019n/an/a

-US$11m

Dec 31 2018US$318kUS$300k

-US$7m

Sep 30 2018n/an/a

-US$1m

Jun 30 2018n/an/a

-US$2m

Mar 31 2018n/an/a

-US$3m

Dec 31 2017US$815kUS$300k

-US$4m

Sep 30 2017n/an/a

-US$12m

Jun 30 2017n/an/a

-US$13m

Mar 31 2017n/an/a

-US$58m

Dec 31 2016US$694kUS$25k

-US$58m

Tazminat ve Piyasa: Jeff's total compensation ($USD632.83K) is above average for companies of similar size in the German market ($USD418.12K).

Tazminat ve Kazançlar: Jeff's compensation has been consistent with company performance over the past year.

CEO

Jeff Eisenberg (57 yo)

5.8yrs

Görev süresi

US$632,827

Tazminat

Mr. Jeffrey F. Eisenberg, also known as Jeff, Esq., has been the Chief Executive Officer of Xenetic Biosciences, Inc. since October 26, 2017; has been its Director since July 11, 2016 and also serves as it...

Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Jeffrey Eisenberg
CEO, President & Director5.8yrsUS$632.83kVeri yok
James Parslow
CFO, COO & Corporate Secretary6.3yrsUS$473.99k0%
€ 0
Curtis Lockshin
Chief Scientific Officer6.6yrsUS$470.37k0%
€ 0

6.3yrs

Ortalama Görev Süresi

58yo

Ortalama Yaş

Deneyimli Yönetim: 3XB0's management team is seasoned and experienced (6.3 years average tenure).

Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Jeffrey Eisenberg
CEO, President & Director7.1yrsUS$632.83kVeri yok
Adam Logal
Independent Chairman of the Board6yrsUS$59.56k0%
€ 0
Roger Kornberg
Independent Director7.5yrsUS$59.56k0%
€ 0
Firdaus Dastoor
Independent Director9.6yrsUS$59.56k0%
€ 0
James Callaway
Independent Director6yrsUS$59.56k0%
€ 0
Guenther Koehne
Member of Scientific Advisory Board4.3yrsVeri yokVeri yok
Matthew Frigault
Member of Scientific Advisory Board4.6yrsVeri yokVeri yok
Alexey Vinogradov
Independent Director4.1yrsUS$59.56k1.23%
€ 61.4k
Grigory Borisenko
Independent Non-Executive Director3.9yrsUS$59.56kVeri yok
Maksim Mamonkin
Member of Scientific Advisory Board3.5yrsVeri yokVeri yok
Allan Tsung
Member of Scientific Advisory Board1.3yrsVeri yokVeri yok
Jonathan Spicer
Member of Scientific Advisory Boardless than a yearVeri yokVeri yok

4.4yrs

Ortalama Görev Süresi

57yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: 3XB0's board of directors are considered experienced (4.4 years average tenure).